Malaria prophylaxis;PROPHYLAXIE DU PALUDISME

Revue du Praticien

Volumn 48, Issue 3, 1998, Pages 279-286

  Bouchaud, Olivier ^a   Longuet, Christophe ^a   Coulaud, Jean Pierre ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; DIETHYLTOLUAMIDE; DOXYCYCLINE; INSECTICIDE; MEFLOQUINE; PROGUANIL; UNCLASSIFIED DRUG;

BED NET; CHEMOPROPHYLAXIS; ECONOMICS; HUMAN; MALARIA; MALARIA CONTROL; PLASMODIUM FALCIPARUM; RISK ASSESSMENT; SHORT SURVEY; TRAVEL;

ANTIMALARIALS; DRUG RESISTANCE; ENDEMIC DISEASES; HUMANS; MALARIA; PATIENT COMPLIANCE; PRIMARY PREVENTION; RISK FACTORS; TRAVEL;

EID: 0032007290     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. Fisch A, Santin A, Prazuck T, Bargain P, Lafaix C. Malaria chemoprophylaxis of 5 497 travellers departing from Paris Air-ports to eight tropical destination: A 1-year (1995-6) prospective randomized epidemiological survey. 5th International Conference on Travel Medecine, Genève, 1997, abstract no 6.
2. Lobel HO, Phillips-Howard PA, Brandling-Bennett AD et al. Malaria incidence and prevention among European and North American travellers to Kenya. Bull WHO 1990; 68: 209-15.
3. Behrens RH, Roberts JA. Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A and typhoid in travellers. Br Med J 1994; 309: 918-22.
4. CNRMI. Paris, 1996; bulletin no 10-11.
5. Bradley D. Prophylaxis against malaria for travellers from the United Kingdom. Br Med J 1993; 306: 1247-52.
6. Armengaud M. Arguments against chemoprophylaxis in areas at low risk for chloroquine-resistant Plasmodium falciparum. J Trav Med 1995; 2: 4-5.
7. Steffen R. Travel medicine prevention based on epidemiological data. Trans R Soc Trop Med Hyg 1991; 85: 156-62.
8. Voyages internationaux et santé. Vaccinations exigées et conseils d'hygiène. Genève: Who 1997.
9. Actualisation des recommandations sanitaires pour les voyageurs. BEH, 1996: no 23.
10. Coulaud JP. La prophylaxie du paludisme. Cahiers Santé 1993; 3: 315-22.
11. Noiry JP. La prévention du paludisme des voyageurs en 1992. Rev Prescrire 1992; 12: 137-42.
12. Raccurt CP, Dumestre-Toulet V, Abraham E et al. Failure of falciparum malaria prophylaxis by mefloquine in travellers from West Africa. Am J Trop Med Hyg 1991; 45: 319-24.
13. Day JH, Behrens RH. Delay in onset of malaria with mefloquine prophylaxis. Lancet 1995; 345: 398.
14. Bouchaud O, Lebras J. Paludisme. In: Carbon C, Régnier B, Saimot AG, VildéJL, Yeni P (eds). Paris: Flammarion Médecine-Sciences, 1994: 337-63.
15. Phillips MA, Kass RB. User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis. J Trav Med 1996; 3: 40-5.
16. Schlagenhauf P. Mefloquine, methodologies, and the media. J Trav Med 1996; 3: 197-9.
17. Steffen R, Fuchs E, Schidkknecht J et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993; 341: 848-51.
18. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. Br Med J 1996; 313: 525-8.
19. Schlagenhauf P, Steffen R, Lobel H et al. Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Intern Health 1996; 1: 485-94.
20. Hatz C. Nouveautés concernant la prévention médicamenteuse du paludisme pour les séjours de courte durée. Med Hyg 1997; 55: 1121-4.
21. Steketee RW, Wirima JJ, Slutsker L et al. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. Am J Trop Med Hyg 1996; 55 (suppl): 50-6.
22. Lobel HO, Miani M, Eng T et al. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341: 848-51.
23. Nothdurft HD, Jelinek T, Pechel SM et al. Stand-by treatment of suspected malaria in travellers. Trop Med Parasitol 1995; 46: 161-3.
24. Martet G, Imbert P, Morillon M, Gras C, Touze JE. Prophylaxie du paludisme chez le voyageur: la cure radicale par halofantrine au retour d'une zone d'endémie doit être abandonnée. Med Trop (Mars) 1994; 54: 189.
25. Carme B. Prevention and treatment of malaria in expatriates in Congo. Trends between 1989 and 1992. Ann Soc Belg Med Trop 1993; 73: 91-9.
26. Gozal D, Hengy C, Fadat G. Prolonged malaria prophylaxis with chloroquine and proguanil (chloroguanide) in a nonimmune resident population of an endemic area with a high prevalence of chloroquine resistance. Antimicrob Agents Chemother 1991; 35: 373-6.
27. Anderson SL, Berman J, Kuschner R et al. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann Intern Med 1995; 123: 771-3.
28. Shanks GD. Malaria prevention and prophylaxis. Baillière S Clin Infect Dis 1995; 2: 331-49.